Welltower To Present At J.P. Morgan Healthcare Conference
TOLEDO, Ohio, Jan. 5, 2018 /PRNewswire/ -- Welltower Inc. (NYSE: HCN) will participate in the 36th Annual J.P. Morgan Healthcare Conference to be held at the Westin St. Francis Hotel in San Francisco, California. Tom DeRosa, Chief Executive Officer, along with John Goodey, EVP and Chief Financial Officer, and Mark Shaver, SVP - Strategy will present during a session scheduled for Wednesday, January 10, 2018 at 3:00 p.m. Pacific Time.
Topics covered in the presentation will include:
Health care delivery moving to lower cost settings
Summary of Welltower's capital deployment
Overview of urbanization and consumerism in health care
The audio can be accessed through the following link:
A replay of the presentation will also be available via the above link shortly following the conclusion of the session. The link will expire on April 10, 2018.
About Welltower
Welltower Inc. (NYSE: HCN), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltowertm, a real estate investment trust ("REIT"), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties. More information is available at www.welltower.com.
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...